The U.S. has officially lost its measles elimination status 26 years after it achieved the public health victory.
The announcement by the Pan American Health Organization (PAHO) on Tuesday formalizes what many experts have been saying is a reality on the ground for months: the U.S. is unable to isolate and contain cases of the highly contagious disease.
So far in 2026 the country has seen more than 5,400 cases of the disease—far outpacing 2025’s 2,289 cases—as well as some 10 deaths. In the years after 2000 and until 2024, the U.S. had typically had fewer than 100 cases per year. But vaccine skepticism and declining childhood vaccine rates have driven the disease’s resurgence—with deadly consequences.
On supporting science journalism
If you’re enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Just 92.4 percent of kindergarteners got the mumps, measles and rubella (MMR) vaccine in the 2025-2026 school year—far below the 95 percent rate needed to maintain herd immunity—with state rates as low as 75 percent. And within states, certain communities have even lower vaccination rates, leading to pockets of spread that have overwhelmed public health protections.
“Losing measles elimination status has broader implications than losing a public health designation,” said PAHO director Jarbas Barbosa at a press briefing on Tuesday. “It means the virus has circulated for a prolonged period of time, putting families and communities at risk of preventable illness.”
The resurgence of measles is “a sobering reminder of what happens when vaccination rates decline and decades of public health progress are reversed,” said American Medical Association president Willie Underwood III in a statement.
“The resurgence of measles across the country has caused preventable hospitalizations and deaths and reflects the consequences of growing gaps in community protection,” he said. “We must treat the current measles outbreaks as an urgent call to rebuild trust in science-based recommendations and restore strong, fully-funded public health infrastructure to protect families and communities and prevent the return of diseases once eliminated.”
In the wake of the decision, some public health experts singled out U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr., for particular criticism. Kennedy is a longtime vaccine skeptic and has repeatedly linked the MMR vaccine to autism despite the lack of any good evidence for such a connection.
“RFK Jr. has spent over a decade trying to destroy disease prevention, the last two as HHS secretary, and his public health malpractice is coming home to roost,” said Gregg Gonsalves, a Yale School of Public Health researcher and a member of the health advocacy group Defend Public Health’s coordinating committee, in a statement. “Congress can no longer sit back and twiddle its thumbs.”
In a statement to Scientific American, a Department of Health and Human Services spokesperson defended Kennedy and said that the department has provided states with $100 million in funding to combat measles outbreaks under his leadership.
Critics, however, say HHS—and particularly, the department’s Centers for Disease Control and Prevention—has failed to implement a unified, coordinated, nationwide vaccination campaign or to combat vaccine misinformation.
Quantifying the role of misinformation in the outbreaks is difficult, said PAHO’s Barbosa, but the organization is working with member countries to provide more information to health care workers on the efficacy and safety of vaccines.
“It’s very well known that the main source that families take into account to make their decision to vaccinate is the information provided by nurses and physicians,” Barbosa said. “[Health ministries] need to be prepared to respond to misinformation, providing clear, transparent information to the families and communities, so they can make the best decision.”
Daniel Salas, PAHO’s executive manager for immunizations, said at the same press event that the U.S. has already begun intensifying vaccination efforts, particularly in areas with low coverage that have ongoing active transmission of measles. But the country needs to submit a corrective action plan that offers more detail on how it intends to fight the outbreaks in order to begin the process toward regaining its elimination status, he said.
“According to this framework, we are expecting the U.S. to present this corrective plan of action in the coming weeks,” Salas said. That could involve strategies such as increased surveillance to detect new cases early, rapid response to limit outbreaks and efforts to vaccinate at-risk populations.
“This necessitates the deployment of teams and adequate lab laboratory support, and these things require funding,” said PAHO’s assistant director Rhonda Sealey-Thomas.
The decision to revoke the U.S.’s elimination status comes a year after PAHO made the same call for Canada, as that country dealt with an outbreak that led to more than 5,000 cases and two deaths. In response, the Canadian government launched a vaccination campaign in communities with historically low immunization rates, and in October it declared the outbreak to be over. Canada must go a year without measles cases spreading before it can regain its elimination status, however. (It recently reached the 60-day mark.) PAHO had also previously revoked elimination status from Venezuela and Brazil in 2018 and 2019, respectively, but their status was later restored.
The U.S. is far from alone in this setback: the U.K., Mexico, Bolivia, Spain, Austria, Armenia, Azerbaijan and Uzbekistan also lost their measles elimination status this year.
Editor’s Note (11/17/26): This is a breaking news story and may be updated.
